無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

摂取型センサーの世界市場:タイプ、アプリケーション(モニタリング、診断イメージング、医薬品管理)、エンドユーザー(ヘルスケア、スポーツ&フィットネス)、地域別の成長率、動向および予測(2018年〜2023年)

Global Ingestible Sensors Market - Segmented by type, Applications (Monitoring, Diagnostic Imaging, Medication Management), End User (Healthcare, Sports & Fitness), and Region - Growth, Trends, and Forecast (2018 - 2023)

発行 Mordor Intelligence LLP 商品コード 704862
出版日 ページ情報 英文 93 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.36円で換算しております。
Back to Top
摂取型センサーの世界市場:タイプ、アプリケーション(モニタリング、診断イメージング、医薬品管理)、エンドユーザー(ヘルスケア、スポーツ&フィットネス)、地域別の成長率、動向および予測(2018年〜2023年) Global Ingestible Sensors Market - Segmented by type, Applications (Monitoring, Diagnostic Imaging, Medication Management), End User (Healthcare, Sports & Fitness), and Region - Growth, Trends, and Forecast (2018 - 2023)
出版日: 2018年08月18日 ページ情報: 英文 93 Pages
概要

摂取型センサー市場は、予測期間(2018年〜2023年)に20.06%以上のCAGRで成長する見込みです。過去5年間にわたり、医療業界は、ウェアラブルおよび埋め込み型技術のような技術革新によって成長が推進されてきました。摂取型センサーは、医療分野における革新であり、急速に重要性を増しているデジタル医薬品(スマートピル)の構成要素です。医療分野のセンサーは、病状を治療する一環として、患者の生活習慣行動を理解するために主に使用されています。摂取型センサーは、ヘルスケア部門の主目的をサポートすることは別として、スマートピル技術に導入されることによって遠隔患者モニタリングの余地を作り出しています。

当レポートでは、世界の摂取型センサー市場を調査し、全体的な市場動向、タイプ・アプリケーション・エンドユーザー・地域別の詳細動向、市場成長への影響要因の分析、競合情勢、主要企業のプロファイルなどを包括的にまとめています。

目次

第1章 イントロダクション

  • 調査成果
  • 市場の定義
  • 調査の前提条件

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場の分析

  • 市場概要
  • 産業魅力 - ファイブフォース分析モデル
    • サプライヤーの交渉力
    • 消費者の交渉力
    • 新規参入の脅威
    • 代替品の脅威
    • 競争的競争の強さ
  • 業界バリューチェーン分析
  • 産業政策

第5章 市場のダイナミクス

  • 市場の成長因子
    • 医療制度のコンプライアンスの必要性
    • 技術進歩の拡大
  • 市場の阻害因子
    • 技術進歩に伴うコストとセキュリティ上の懸念

第6章 市場のセグメンテーション

  • アプリケーション別
    • モニタリング
    • 診断イメージング
    • 薬物療法管理
  • エンドユーザー別
    • ヘルスケアプロバイダー
    • スポーツ&フィットネス
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 南米
    • 中東・アフリカ

第7章 競合他社の情報- 企業プロファイル

  • Proteus Digital Health, Inc
  • オリンパス
  • 大塚製薬
  • Adhere Tech
  • Medtronic PLC (Given Imaging Ltd)
  • CapsoVision Inc.
  • HQ, Inc.
  • IntroMedic Co., Ltd.
  • RF Co., Ltd.

第8章 市場投資分析

第9章 市場の将来展望

目次
Product Code: 63626

The Ingestible Sensors Market is expected to register a CAGR of over 20.06% during the forecast period (2018 - 2023). The healthcare industry, over the past five years, has been driven by the technology-based and -enabled innovations, like the wearable and embeddable technology. The ingestible sensors are components of digital medicines (also smart pills), an innovation in the healthcare sector and is gaining importance rapidly. Sensors in the healthcare sector are majorly used to understand the lifestyle behaviors of the patients as a part of treating their medical condition. Ingestible sensors, apart from supporting the main purpose in the healthcare sector also provides scope for remote patient monitoring by being deployed in the smart pill technology.

The technological advancements in the ingestible sensors are focused towards addressing the need for medical regime compliance among the senior citizens and also eliminate the need for repeated physical checkups. A significant share of healthcare technology companies and digital health startups are venturing into digital medicine technology developing their own ingestible sensors, anticipating the rapid adoption by the end users during the forecast period. Since these sensors are made up of digestible metals, like copper & magnesium and doesn't require external power to get activated, they are being slowly accepted by the end-users. The ingestible sensor technology is highly regulated and needs to be approved by FDA for the users to prescribe it to their patients. Proteus Digital Health Inc. is the first digital technology company that was given FDA approval for its ingestible tracking system enabled pill, Abilify MyCite, in 2017 after conducting more than 400 clinical trials. However, the cost of these ingestible sensors and concerns around technologies that store information of the patients' medication-taking-behavior are some of the challenges, which impact the growth of the market.

Governments across Asian regions, like India and China ("Healthy China 2030") are undertaking several initiatives aimed at improving healthcare infrastructure, and offer significant support for innovation. These investments are likely to contribute to the adoption of the ingestible sensors in the region. Going forward, advancements in the nanosensors and the flexible electronics are expected to shape the ingestible sensors technology during the forecast period.

Need to Address the Medical Regime Non-compliance Drives the Ingestible Sensors Market

According to Centers for Disease Control and Prevention (CDC), a leading national public health institute of the US, more than 150 million Americans would be prescribed chronic medications by 2020, among which about 50% are not continued as prescribed. The center mentioned that non-adherence causes failure of treatments, which leads to about 125 thousand deaths per year, in United States alone, thus, impacting the mortality rate in the region. This non-compliance is also evident in the senior citizens across regions with chronic diseases need continuous monitoring, and in most cases, physical checkups may become a challenge over a period of time. Considering the fact that more than 50% of hospital deaths occur in patients who are not continuously monitored, there exists a definite need, which the ingestible sensors appropriately address through smart pills. The rise in the number of death cases across regions due to non-availability of remote low-cost care management also drives the market under study.

Europe to be the Fastest Growing Market

The less invasive healthcare technology is expected to have a huge demand from Europe during the forecast period, considering the government initiatives in the region in line with the aging population and healthcare compliance. European government's e-health strategy supports the growth of the digital medicines through encouraging investments by the member regions in large-scale deployment of digitally-enabled, integrated, person-centered care. Through Health EU project the region plans to develop technological platform around patients using a whole range of leading-edge technologies, like portable sensors, implants, nanomedicine techniques, and medical imaging. These initiatives indicate the growth rate of the region in the ingestible sensor market. Geographically, North America has the largest market share in 2017 considering the high-quality healthcare systems, modern medical technology, and high disposable incomes in the region. Healthcare providers in a few areas in the North America have started prescribing ingestible sensor-based digital medicines.

Key Developments in the Ingestible Sensors Market

Feb 2018: Proteus Digital Health, Inc., the company with the first FDA approved smart pill/digital medicine, announced its pipeline of 31 digital medicines for treating infectious diseases, mental health, cardiovascular and metabolic conditions, and oncology. The company plans to collaborate with Otsuka Pharmaceutical Company and others in order to extend the digital medicine to treat other chronic devices.

Ingestible Sensors Market Major Players: PROTEUS DIGITAL HEALTH INC., ADHERE TECH, GIVEN IMAGING LTD, OTSUKA PHARMACEUTICAL, MEDTRONIC PLC (GIVEN IMAGING LTD), OLYMPUS MEDICAL TECHNOLOGY, CAPSOVISION INC., HQ, INC., INTROMEDIC CO., LTD and RF CO., LTD., among others.

Reasons to Purchase Ingestible Sensors Market Report

Current and future ingestible sensors market outlook in the developed and emerging markets

Analyzing various perspectives of the market with the help of Porter's five forces analysis

The segment that is expected to dominate the market

Regions that are expected to witness the fastest growth during the forecast period

Identifying the latest developments, market shares, and strategies employed by the major market players

3-month analyst support, along with the Market Estimate sheet (in Excel)

Customization of the Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs

Table of Contents

1. Introduction

  • 1.1 Key Study Deliverables
  • 1.2 Market Definition
  • 1.3 Study Assumptions

2. Research Methodology

3. Executive Summary

4. Market Insights

  • 4.1 Ingestible Sensors Market Overview
  • 4.2 Industry Attractiveness-Porter's Five Forces Model
    • 4.2.1 Bargaining Power Of Suppliers
    • 4.2.2 Bargaining Power Of The Consumers
    • 4.2.3 Threat Of New Entrants
    • 4.2.4 Threat Of Substitutes
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Industry Value Chain Analysis
  • 4.4 Industry Policies

5. Market Dynamics

  • 5.1 Ingestible Sensors Market Drivers
    • 5.1.1 Need for medical regime compliance
    • 5.1.2 Growing Technological Advancements
  • 5.2 Ingestible Sensors Market Restraints
    • 5.2.1 Increasing Costs and security concerns with Technological Advancement

6. Ingestible Sensors Market Segmentation

  • 6.1 Ingestible Sensors Market By Applications
    • 6.1.1 Monitoring
    • 6.1.2 Diagnostic Imaging
    • 6.1.3 Medication Management
  • 6.2 Ingestible Sensors Market By End-users
    • 6.2.1 Healthcare Providers
    • 6.2.2 Sports and Fitness
  • 6.3 Ingestible Sensors Market By Region
    • 6.3.1 North America
    • 6.3.2 Europe
    • 6.3.3 Asia-Pacific
    • 6.3.4 South America
    • 6.3.5 Middle-East and Africa

7. Competitive Intelligence - Company Profiles

  • 7.1 Proteus Digital Health, Inc
  • 7.2 Olympus Corporation
  • 7.3 Otsuka Pharmaceutical
  • 7.4 Adhere Tech
  • 7.5 Medtronic PLC (Given Imaging Ltd)
  • 7.6 CapsoVision Inc.
  • 7.7 HQ, Inc.
  • 7.8 IntroMedic Co., Ltd.
  • 7.9 RF Co., Ltd.

8. Ingestible Sensors Market Investment Analysis

9. Future of Ingestible Sensors Market

Back to Top